Inovio Pharmaceuticals, Inc. (INO)
NASDAQ: INO · Real-Time Price · USD
2.070
+0.050 (2.48%)
Dec 5, 2025, 4:00 PM EST - Market closed
Inovio Pharmaceuticals Employees
Inovio Pharmaceuticals had 134 employees as of December 31, 2024. The number of employees increased by 12 or 9.84% compared to the previous year.
Employees
134
Change (1Y)
12
Growth (1Y)
9.84%
Revenue / Employee
$1,361
Profits / Employee
-$806,660
Market Cap
142.22M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
INO News
- 3 days ago - Inovio Pharmaceuticals, Inc. (INO) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript - Seeking Alpha
- 17 days ago - INOVIO to Participate in December Investor Conferences - PRNewsWire
- 23 days ago - Inovio 3Q25 Review: EPS Miss, $25M Offering, And INO-3107 Progress - Seeking Alpha
- 24 days ago - INOVIO Announces Pricing of $25 Million Public Offering - PRNewsWire
- 25 days ago - Inovio Pharmaceuticals, Inc. (INO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 25 days ago - INOVIO Announces Proposed Public Offering - PRNewsWire
- 25 days ago - INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights - PRNewsWire
- 4 weeks ago - INOVIO Completes Rolling BLA Submission Seeking Accelerated Approval for INO-3107 as a Treatment for RRP in Adults - PRNewsWire